Literature DB >> 15727506

A comparison of anticonvulsants in the treatment of impulsive aggression.

Matthew S Stanford1, Laura E Helfritz, Sarah M Conklin, Nicole R Villemarette-Pittman, Kevin W Greve, Donald Adams, Rebecca J Houston.   

Abstract

This study compared the behavioral effects of 3 anticonvulsants in impulsive aggressive men. In a double-blind, placebo-controlled, parallel groups design, participants were randomly assigned to 1 of 4 6-week treatments: phenytoin (n = 7), carbamazepine (n = 7), valproate (n = 7), or placebo (n = 8). The efficacy measure was the average aggression score, a global severity index from the Overt Aggression Scale (J. M. Silver & S. C. Yudofsky, 1991). Analysis showed a significant reduction in impulsive aggression during all 3 anticonvulsant conditions compared with placebo. However, the treatment effect during carbamazepine administration was slightly delayed compared with phenytoin and valproate. These findings suggest that increased use of anticonvulsants could make a significant impact in the control of impulsive aggression in both mental health and criminal justice settings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15727506     DOI: 10.1037/1064-1297.13.1.72

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  15 in total

Review 1.  Neuropsychiatry of aggression.

Authors:  Scott D Lane; Kimberly L Kjome; F Gerard Moeller
Journal:  Neurol Clin       Date:  2011-02       Impact factor: 3.806

2.  Off-licence prescribing and regulation in psychiatry: current challenges require a new model of governance.

Authors:  Philip Sugarman; Amy Mitchell; Catherine Frogley; Geoffrey L Dickens; Marco Picchioni
Journal:  Ther Adv Psychopharmacol       Date:  2013-08

3.  Chronic tiagabine administration and aggressive responding in individuals with a history of substance abuse and antisocial behavior.

Authors:  Joshua L Gowin; Charles E Green; Joseph L Alcorn; Alan C Swann; F Gerard Moeller; Scott D Lane
Journal:  J Psychopharmacol       Date:  2011-07-05       Impact factor: 4.153

4.  Phenytoin normalizes exaggerated fear behavior in p-chlorophenylalanine (PCPA)-treated rats.

Authors:  Cathryn R Hughes; N Bradley Keele
Journal:  Epilepsy Behav       Date:  2006-10-12       Impact factor: 2.937

Review 5.  Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain.

Authors:  Alan B Ettinger; Charles E Argoff
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

Review 6.  Pharmacological interventions for antisocial personality disorder.

Authors:  Najat Khalifa; Conor Duggan; Jutta Stoffers; Nick Huband; Birgit A Völlm; Michael Ferriter; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

7.  Characterizing aggressive behavior with the Impulsive/Premeditated Aggression Scale among adolescents with conduct disorder.

Authors:  Charles W Mathias; Matthew S Stanford; Dawn M Marsh; Paul J Frick; F Gerard Moeller; Alan C Swann; Donald M Dougherty
Journal:  Psychiatry Res       Date:  2007-03-26       Impact factor: 3.222

8.  Acute topiramate differentially affects human aggressive responding at low vs. moderate doses in subjects with histories of substance abuse and antisocial behavior.

Authors:  Scott D Lane; Joshua L Gowin; Charles E Green; Joel L Steinberg; F Gerard Moeller; Don R Cherek
Journal:  Pharmacol Biochem Behav       Date:  2009-04       Impact factor: 3.533

9.  Trait impulsivity and response inhibition in antisocial personality disorder.

Authors:  Alan C Swann; Marijn Lijffijt; Scott D Lane; Joel L Steinberg; F Gerard Moeller
Journal:  J Psychiatr Res       Date:  2009-04-05       Impact factor: 4.791

10.  Pharmacologic treatment of impulsive aggression with antiepileptic drugs.

Authors:  Matthew S Stanford; Nathaniel E Anderson; Sarah L Lake; Robyn M Baldridge
Journal:  Curr Treat Options Neurol       Date:  2009-09       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.